Dexrazoxane

SAVENE 20 mg/ml POLVO PARA CONCENTRADO Y DISOLVENTE PARA SOLUCION PARA PERFUSION

20 mg polvo y disolvente para concentrado para solución para perfusiónSpainMarketedAuthorised 20 Feb 2007

In other countries

The same active substances on other registers, the same brand first.

SaveneEuropean Union · CNX Therapeutics Ireland LimitedSame brand
SaveneCroatiaSame brand
SaveneItaly · Soluzione per infusione · CNX Therapeutics Ireland LimitedSame brand
Savene 500 mg, poeder en oplosmiddel voor oplossing voor infusieNetherlands · Oplosmiddel voor parenteraal gebruik, Poeder voor oplossing voor injectie · CNX Therapeutics Ireland LimitedSame brand
CardioxaneItaly · Polvere per soluzione per infusione endovenosa · CNX Therapeutics Ireland LimitedSame form
Cardioxane 500 mg poeder voor oplossing voor infusieNetherlands · Poeder voor oplossing voor infusie · CNX Therapeutics Ireland LimitedSame form

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Dexrazoxane

SAVENE 20 mg/ml POLVO PARA CONCENTRADO Y DISOLVENTE PARA SOLUCION PARA PERFUSION

20 mg polvo y disolvente para concentrado para solución para perfusiónSpainMarketedAuthorised 20 Feb 2007

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

e.g. Cardioxane

New Zealand · Inj 500 mg

Dexrazoxane HydrochlorideUnited States · 250MG BASE/VIAL, 500MG BASE/VIAL · injectable · MSN

TotectUnited States · 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · injectable · Clinigen

ZinecardUnited States · 250MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · injectable · Pfizer

CardioxaneBrazil · Adium S.A.

Dexrazoxane for InjectionCanada · 250 MG / VIAL · Powder For Solution · Juno Pharma Canada INC.

Dexrazoxane for InjectionCanada · 250 MG / VIAL · Powder For Solution · Hikma Canada Limited

ZinecardCanada · 250 MG / VIAL · Powder For Solution · Pfizer Canada Ulc

Packs

Pack	Code	Status
SAVENE 20 mg/ml POLVO PARA CONCENTRADO Y DISOLVENTE PARA SOLUCION PARA PERFUSION, 10 viales + 3 frascos de disolvente	658509

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Dexrazoxane
Strength: 20 mg
Dosage form: polvo y disolvente para concentrado para solución para perfusión
Route: vía intravenosa
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 20 Feb 2007
Registration: 06350001
Marketing authorisation holder: Cnx Therapeutics Ireland Limited
Procedure: EU centralised
Supply: Uso Hospitalario